Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 68

Similar articles for PubMed (Select 23300010)

1.

Survival outcomes in acute invasive fungal sinusitis: a systematic review and quantitative synthesis of published evidence.

Turner JH, Soudry E, Nayak JV, Hwang PH.

Laryngoscope. 2013 May;123(5):1112-8. doi: 10.1002/lary.23912. Epub 2013 Jan 8. Review.

PMID:
23300010
2.

Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.

Moen MD, Lyseng-Williamson KA, Scott LJ.

Drugs. 2009;69(3):361-92. doi: 10.2165/00003495-200969030-00010. Review.

PMID:
19275278
3.

Treatment of invasive fungal sinusitis with liposomal amphotericin B: a report of four cases.

Sungkanuparph S, Sathapatayavongs B, Kunachak S, Luxameechanporn T, Cheewaruangroj W.

J Med Assoc Thai. 2001 Apr;84(4):593-601.

PMID:
11460976
4.

Invasive fungal rhinosinusitis: a 15-year experience with 29 patients.

Monroe MM, McLean M, Sautter N, Wax MK, Andersen PE, Smith TL, Gross ND.

Laryngoscope. 2013 Jul;123(7):1583-7. doi: 10.1002/lary.23978. Epub 2013 Feb 16.

PMID:
23417294
5.

Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.

Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.

Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.

6.
7.

Aggressive combination treatment for invasive fungal sinusitis in immunocompromised patients.

Rizk SS, Kraus DH, Gerresheim G, Mudan S.

Ear Nose Throat J. 2000 Apr;79(4):278-80, 282, 284-5.

PMID:
10786391
8.

Efficacy outcomes in a randomised trial of liposomal amphotericin B based on revised EORTC/MSG 2008 definitions of invasive mould disease.

Cornely OA, Maertens J, Bresnik M, Ebrahimi R, Dellow E, Herbrecht R, Donnelly JP.

Mycoses. 2011 Sep;54(5):e449-55. doi: 10.1111/j.1439-0507.2010.01947.x. Epub 2010 Oct 11.

PMID:
21039936
9.

Craniocerebral aspergillosis of sinonasal origin in immunocompetent patients: clinical spectrum and outcome in 25 cases.

Siddiqui AA, Shah AA, Bashir SH.

Neurosurgery. 2004 Sep;55(3):602-11; discussion 611-3.

PMID:
15335427
10.

Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.

Neofytos D, Horn D, Anaissie E, Steinbach W, Olyaei A, Fishman J, Pfaller M, Chang C, Webster K, Marr K.

Clin Infect Dis. 2009 Feb 1;48(3):265-73. doi: 10.1086/595846. Erratum in: Clin Infect Dis. 2009 Mar 1;48(5):690.

11.

Allergic fungal sinusitis in children.

Campbell JM, Graham M, Gray HC, Bower C, Blaiss MS, Jones SM.

Ann Allergy Asthma Immunol. 2006 Feb;96(2):286-90. Review.

PMID:
16498849
12.

Prevalence and outcome of fungal infection in patients with severe acute pancreatitis.

Kochhar R, Ahammed SK, Chakrabarti A, Ray P, Sinha SK, Dutta U, Wig JD, Singh K.

J Gastroenterol Hepatol. 2009 May;24(5):743-7. doi: 10.1111/j.1440-1746.2008.05712.x. Epub 2009 Feb 9.

PMID:
19220667
13.

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.

Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, Cornely OA, Bourque MR, Lupinacci RJ, Sable CA, dePauw BE.

N Engl J Med. 2004 Sep 30;351(14):1391-402.

14.

Treatment outcomes in acute invasive fungal rhinosinusitis.

Zuniga MG, Turner JH.

Curr Opin Otolaryngol Head Neck Surg. 2014 Jun;22(3):242-8. doi: 10.1097/MOO.0000000000000048. Review.

PMID:
24756031
15.

Prospective interventional study to evaluate the efficacy and safety of liposomal amphotericin B as prophylaxis of fungal infections in high-risk liver transplant recipients.

Castroagudín JF, Pontón C, Bustamante M, Otero E, Martínez J, Tomé S, Conde R, Segade FR, Delgado M, Brage A, Galbán C, Varo E.

Transplant Proc. 2005 Nov;37(9):3965-7.

PMID:
16386598
16.

Prognosis of acute invasive fungal rhinosinusitis related to underlying disease.

Valera FC, do Lago T, Tamashiro E, Yassuda CC, Silveira F, Anselmo-Lima WT.

Int J Infect Dis. 2011 Dec;15(12):e841-4. doi: 10.1016/j.ijid.2011.08.005. Epub 2011 Oct 2.

17.

Invasive fungal sinusitis in patients undergoing bone marrow transplantation.

Drakos PE, Nagler A, Or R, Naparstek E, Kapelushnik J, Engelhard D, Rahav G, Ne'emean D, Slavin S.

Bone Marrow Transplant. 1993 Sep;12(3):203-8. Review.

PMID:
8241977
18.

Pediatric invasive sinonasal Scopulariopsis brevicaulis--a case report and literature review.

Gluck O, Segal N, Yariv F, Polacheck I, Puterman M, Greenberg D, Daniel B.

Int J Pediatr Otorhinolaryngol. 2011 Jul;75(7):891-3. doi: 10.1016/j.ijporl.2011.03.026. Epub 2011 May 4. Review.

PMID:
21543124
19.

A multicenter, randomized trial of fluconazole versus amphotericin B for empiric antifungal therapy of febrile neutropenic patients with cancer.

Winston DJ, Hathorn JW, Schuster MG, Schiller GJ, Territo MC.

Am J Med. 2000 Mar;108(4):282-9.

PMID:
11014720
20.

The role of itraconazole in recalcitrant fungal sinusitis.

Seiberling K, Wormald PJ.

Am J Rhinol Allergy. 2009 May-Jun;23(3):303-6. doi: 10.2500/ajra.2009.23.3315.

PMID:
19490806
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk